Portfolio, new launches to help pharma company Abbott India’s stock | News on Markets
[ad_1] Premium Abbott’s December quarter performance was mixed. Revenues were in line with estimates and operational parameters better than expected | Representative image The stock of Abbott India, the largest listed multinational pharmaceutical company, hit its highest early February and has added over 25 per cent to its returns since the start of the year. … Read more